Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Growth (Status and Outlook) 2022-2028

  • LP 4929006
  • 102 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Drugs for Vancomycin-Resistant Enterococcus Faecium will have significant change from previous year. According to our (LP Information) latest study, the global Drugs for Vancomycin-Resistant Enterococcus Faecium market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Drugs for Vancomycin-Resistant Enterococcus Faecium market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Drugs for Vancomycin-Resistant Enterococcus Faecium market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Drugs for Vancomycin-Resistant Enterococcus Faecium market, reaching US$ million by the year 2028. As for the Europe Drugs for Vancomycin-Resistant Enterococcus Faecium landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Drugs for Vancomycin-Resistant Enterococcus Faecium players cover Alchemia Limited, Alvogen, Aphios Corporation, and Cellceutix Corporation, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Vancomycin-Resistant Enterococcus Faecium market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Daptomycin

Linezolid

Quinupristin/dalfopristin

Ampicillin

Chloramphenicol

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospital

Clinic

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Alchemia Limited

Alvogen

Aphios Corporation

Cellceutix Corporation

Enanta Pharmaceuticals

Helix BioMedix

LegoChem Biosciences

Lytix Biopharma

MGB Biopharma Limited

Microbiotix

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2017-2028

2.1.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Segment by Type

2.2.1 Daptomycin

2.2.2 Linezolid

2.2.3 Quinupristin/dalfopristin

2.2.4 Ampicillin

2.2.5 Chloramphenicol

2.2.6 Others

2.3 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type

2.3.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Type (2017-2022)

2.4 Drugs for Vancomycin-Resistant Enterococcus Faecium Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application

2.5.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Application (2017-2022)

3 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Player

3.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Players

3.1.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Players (2020-2022)

3.1.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Players (2020-2022)

3.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Drugs for Vancomycin-Resistant Enterococcus Faecium by Regions

4.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Regions (2017-2022)

4.2 Americas Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth (2017-2022)

4.3 APAC Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth (2017-2022)

4.4 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth (2017-2022)

4.5 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth (2017-2022)

5 Americas

5.1 Americas Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2017-2022)

5.2 Americas Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2017-2022)

5.3 Americas Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Region (2017-2022)

6.2 APAC Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2017-2022)

6.3 APAC Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium by Country (2017-2022)

7.2 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2017-2022)

7.3 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium by Region (2017-2022)

8.2 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2017-2022)

8.3 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Forecast by Regions (2023-2028)

10.1.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Forecast by Regions (2023-2028)

10.1.2 Americas Drugs for Vancomycin-Resistant Enterococcus Faecium Forecast

10.1.3 APAC Drugs for Vancomycin-Resistant Enterococcus Faecium Forecast

10.1.4 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Forecast

10.1.5 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Forecast

10.2 Americas Drugs for Vancomycin-Resistant Enterococcus Faecium Forecast by Country (2023-2028)

10.2.1 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.2.2 Canada Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.2.3 Mexico Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.2.4 Brazil Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.3 APAC Drugs for Vancomycin-Resistant Enterococcus Faecium Forecast by Region (2023-2028)

10.3.1 China Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.3.2 Japan Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.3.3 Korea Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.3.4 Southeast Asia Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.3.5 India Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.3.6 Australia Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.4 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Forecast by Country (2023-2028)

10.4.1 Germany Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.4.2 France Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.4.3 UK Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.4.4 Italy Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.4.5 Russia Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.5 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Forecast by Region (2023-2028)

10.5.1 Egypt Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.5.2 South Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.5.3 Israel Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.5.4 Turkey Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.5.5 GCC Countries Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast

10.6 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Forecast by Type (2023-2028)

10.7 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Alchemia Limited

11.1.1 Alchemia Limited Company Information

11.1.2 Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

11.1.3 Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Alchemia Limited Main Business Overview

11.1.5 Alchemia Limited Latest Developments

11.2 Alvogen

11.2.1 Alvogen Company Information

11.2.2 Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

11.2.3 Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Alvogen Main Business Overview

11.2.5 Alvogen Latest Developments

11.3 Aphios Corporation

11.3.1 Aphios Corporation Company Information

11.3.2 Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

11.3.3 Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Aphios Corporation Main Business Overview

11.3.5 Aphios Corporation Latest Developments

11.4 Cellceutix Corporation

11.4.1 Cellceutix Corporation Company Information

11.4.2 Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

11.4.3 Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Cellceutix Corporation Main Business Overview

11.4.5 Cellceutix Corporation Latest Developments

11.5 Enanta Pharmaceuticals

11.5.1 Enanta Pharmaceuticals Company Information

11.5.2 Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

11.5.3 Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Enanta Pharmaceuticals Main Business Overview

11.5.5 Enanta Pharmaceuticals Latest Developments

11.6 Helix BioMedix

11.6.1 Helix BioMedix Company Information

11.6.2 Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

11.6.3 Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Helix BioMedix Main Business Overview

11.6.5 Helix BioMedix Latest Developments

11.7 LegoChem Biosciences

11.7.1 LegoChem Biosciences Company Information

11.7.2 LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

11.7.3 LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 LegoChem Biosciences Main Business Overview

11.7.5 LegoChem Biosciences Latest Developments

11.8 Lytix Biopharma

11.8.1 Lytix Biopharma Company Information

11.8.2 Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

11.8.3 Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Lytix Biopharma Main Business Overview

11.8.5 Lytix Biopharma Latest Developments

11.9 MGB Biopharma Limited

11.9.1 MGB Biopharma Limited Company Information

11.9.2 MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

11.9.3 MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 MGB Biopharma Limited Main Business Overview

11.9.5 MGB Biopharma Limited Latest Developments

11.10 Microbiotix

11.10.1 Microbiotix Company Information

11.10.2 Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

11.10.3 Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Microbiotix Main Business Overview

11.10.5 Microbiotix Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Daptomycin

Table 3. Major Players of Linezolid

Table 4. Major Players of Quinupristin/dalfopristin

Table 5. Major Players of Ampicillin

Table 6. Major Players of Chloramphenicol

Table 7. Major Players of Others

Table 8. Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2017-2022) & ($ Millions)

Table 10. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Type (2017-2022)

Table 11. Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 12. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2017-2022) & ($ Millions)

Table 13. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Application (2017-2022)

Table 14. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Players (2020-2022) & ($ Millions)

Table 15. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Player (2020-2022)

Table 16. Drugs for Vancomycin-Resistant Enterococcus Faecium Key Players Head office and Products Offered

Table 17. Drugs for Vancomycin-Resistant Enterococcus Faecium Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 18. New Products and Potential Entrants

Table 19. Mergers & Acquisitions, Expansion

Table 20. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Regions 2017-2022 & ($ Millions)

Table 21. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Regions (2017-2022)

Table 22. Americas Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2017-2022) & ($ Millions)

Table 23. Americas Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Country (2017-2022)

Table 24. Americas Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2017-2022) & ($ Millions)

Table 25. Americas Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Type (2017-2022)

Table 26. Americas Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2017-2022) & ($ Millions)

Table 27. Americas Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Application (2017-2022)

Table 28. APAC Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Region (2017-2022) & ($ Millions)

Table 29. APAC Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Region (2017-2022)

Table 30. APAC Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2017-2022) & ($ Millions)

Table 31. APAC Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Type (2017-2022)

Table 32. APAC Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2017-2022) & ($ Millions)

Table 33. APAC Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Application (2017-2022)

Table 34. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2017-2022) & ($ Millions)

Table 35. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Country (2017-2022)

Table 36. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2017-2022) & ($ Millions)

Table 37. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Type (2017-2022)

Table 38. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2017-2022) & ($ Millions)

Table 39. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Application (2017-2022)

Table 40. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Region (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Region (2017-2022)

Table 42. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Type (2017-2022)

Table 44. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2017-2022) & ($ Millions)

Table 45. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Application (2017-2022)

Table 46. Key Market Drivers & Growth Opportunities of Drugs for Vancomycin-Resistant Enterococcus Faecium

Table 47. Key Market Challenges & Risks of Drugs for Vancomycin-Resistant Enterococcus Faecium

Table 48. Key Industry Trends of Drugs for Vancomycin-Resistant Enterococcus Faecium

Table 49. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 50. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share Forecast by Regions (2023-2028)

Table 51. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 52. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share Forecast by Type (2023-2028)

Table 53. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 54. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share Forecast by Application (2023-2028)

Table 55. Alchemia Limited Details, Company Type, Drugs for Vancomycin-Resistant Enterococcus Faecium Area Served and Its Competitors

Table 56. Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

Table 57. Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 58. Alchemia Limited Main Business

Table 59. Alchemia Limited Latest Developments

Table 60. Alvogen Details, Company Type, Drugs for Vancomycin-Resistant Enterococcus Faecium Area Served and Its Competitors

Table 61. Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

Table 62. Alvogen Main Business

Table 63. Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 64. Alvogen Latest Developments

Table 65. Aphios Corporation Details, Company Type, Drugs for Vancomycin-Resistant Enterococcus Faecium Area Served and Its Competitors

Table 66. Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

Table 67. Aphios Corporation Main Business

Table 68. Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 69. Aphios Corporation Latest Developments

Table 70. Cellceutix Corporation Details, Company Type, Drugs for Vancomycin-Resistant Enterococcus Faecium Area Served and Its Competitors

Table 71. Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

Table 72. Cellceutix Corporation Main Business

Table 73. Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 74. Cellceutix Corporation Latest Developments

Table 75. Enanta Pharmaceuticals Details, Company Type, Drugs for Vancomycin-Resistant Enterococcus Faecium Area Served and Its Competitors

Table 76. Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

Table 77. Enanta Pharmaceuticals Main Business

Table 78. Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 79. Enanta Pharmaceuticals Latest Developments

Table 80. Helix BioMedix Details, Company Type, Drugs for Vancomycin-Resistant Enterococcus Faecium Area Served and Its Competitors

Table 81. Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

Table 82. Helix BioMedix Main Business

Table 83. Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 84. Helix BioMedix Latest Developments

Table 85. LegoChem Biosciences Details, Company Type, Drugs for Vancomycin-Resistant Enterococcus Faecium Area Served and Its Competitors

Table 86. LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

Table 87. LegoChem Biosciences Main Business

Table 88. LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 89. LegoChem Biosciences Latest Developments

Table 90. Lytix Biopharma Details, Company Type, Drugs for Vancomycin-Resistant Enterococcus Faecium Area Served and Its Competitors

Table 91. Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

Table 92. Lytix Biopharma Main Business

Table 93. Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 94. Lytix Biopharma Latest Developments

Table 95. MGB Biopharma Limited Details, Company Type, Drugs for Vancomycin-Resistant Enterococcus Faecium Area Served and Its Competitors

Table 96. MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

Table 97. MGB Biopharma Limited Main Business

Table 98. MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 99. MGB Biopharma Limited Latest Developments

Table 100. Microbiotix Details, Company Type, Drugs for Vancomycin-Resistant Enterococcus Faecium Area Served and Its Competitors

Table 101. Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offered

Table 102. Microbiotix Main Business

Table 103. Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Microbiotix Latest Developments

List of Figures

Figure 1. Drugs for Vancomycin-Resistant Enterococcus Faecium Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Type in 2021

Figure 7. Drugs for Vancomycin-Resistant Enterococcus Faecium in Hospital

Figure 8. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market: Hospital (2017-2022) & ($ Millions)

Figure 9. Drugs for Vancomycin-Resistant Enterococcus Faecium in Clinic

Figure 10. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market: Clinic (2017-2022) & ($ Millions)

Figure 11. Drugs for Vancomycin-Resistant Enterococcus Faecium in Others

Figure 12. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Application in 2021

Figure 14. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Player in 2021

Figure 15. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2017-2022 ($ Millions)

Figure 17. APAC Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2017-2022 ($ Millions)

Figure 18. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2017-2022 ($ Millions)

Figure 20. Americas Drugs for Vancomycin-Resistant Enterococcus Faecium Value Market Share by Country in 2021

Figure 21. Americas Drugs for Vancomycin-Resistant Enterococcus Faecium Consumption Market Share by Type in 2021

Figure 22. Americas Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Application in 2021

Figure 23. United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Region in 2021

Figure 28. APAC Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Application in 2021

Figure 29. China Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Country in 2021

Figure 36. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Type in 2021

Figure 37. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Application in 2021

Figure 38. Germany Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Application in 2021

Figure 46. Egypt Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 52. APAC Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 53. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 55. United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 56. Canada Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 59. China Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 60. Japan Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 61. Korea Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 63. India Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 64. Australia Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 65. Germany Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 66. France Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 67. UK Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 68. Italy Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 69. Russia Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 70. Spain Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 73. Israel Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390